U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07804784) titled 'Postoperative Analgesic Consumption After Preoperative Gabapentin vs Placebo in Breast Cancer Surgery' on Aug. 28.
Brief Summary: The study will be conducted after approval from the Scientific and Ethical Review Committees. Eligible patients will be enrolled after obtaining written informed consent and randomly allocated to Group A (gabapentin) or Group B (placebo). Group A will receive oral gabapentin 600 mg one hour before surgery, while Group B will receive oral placebo (sodium bicarbonate) at the same time.
General anesthesia will be induced with propofol, atracurium, and fentanyl and maintained with sevoflurane using a supragl...